Literature DB >> 8250529

A new inherited prion disease (PrP-P105L mutation) showing spastic paraparesis.

T Kitamoto1, N Amano, Y Terao, Y Nakazato, T Isshiki, T Mizutani, J Tateishi.   

Abstract

We report the clinicopathological findings of 5 patients with an inherited prion disease with a codon 105 (Pro to Leu) mutation. All of the patients had a spastic gait disturbance and progressive dementia without either cerebellar signs, myoclonus, or periodic synchronous discharges. Autopsy of 3 patients revealed numerous amyloid plaques in the cerebral cortex, especially in the motor cortex and the frontal lobe where neuronal loss and severe gliosis were observed in the absence of spongiform changes. The cerebellum was preserved histologically except for only a few amyloid plaques. The pyramidal tracts in the brainstem and spinal cord showed vacuolated changes and a loss of myelin, but no prion protein accumulations. Thus, the prion protein codon 105 mutation is considered to correspond to a new variant of the Gerstmann-Sträussler syndrome with spastic paraparesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8250529     DOI: 10.1002/ana.410340609

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  20 in total

1.  Maspardin is mutated in mast syndrome, a complicated form of hereditary spastic paraplegia associated with dementia.

Authors:  Michael A Simpson; Harold Cross; Christos Proukakis; Anna Pryde; Ruth Hershberger; Arnaud Chatonnet; Michael A Patton; Andrew H Crosby
Journal:  Am J Hum Genet       Date:  2003-10-16       Impact factor: 11.025

2.  Specific amyloid-β42 deposition in the brain of a Gerstmann-Sträussler-Scheinker disease patient with a P105L mutation on the prion protein gene.

Authors:  Fumiko Furukawa; Nobuo Sanjo; Atsushi Kobayashi; Tsuyoshi Hamaguchi; Masahito Yamada; Tetsuyuki Kitamoto; Hidehiro Mizusawa; Takanori Yokota
Journal:  Prion       Date:  2018-11-13       Impact factor: 3.931

3.  Squirrel monkeys (Saimiri sciureus) infected with the agent of bovine spongiform encephalopathy develop tau pathology.

Authors:  P Piccardo; J Cervenak; O Yakovleva; L Gregori; K Pomeroy; A Cook; F S Muhammad; T Seuberlich; L Cervenakova; D M Asher
Journal:  J Comp Pathol       Date:  2011-10-20       Impact factor: 1.311

4.  Recombinant scrapie-like prion protein of 106 amino acids is soluble.

Authors:  T Muramoto; M Scott; F E Cohen; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

Review 5.  Hereditary Human Prion Diseases: an Update.

Authors:  Matthias Schmitz; Kathrin Dittmar; Franc Llorens; Ellen Gelpi; Isidre Ferrer; Walter J Schulz-Schaeffer; Inga Zerr
Journal:  Mol Neurobiol       Date:  2016-06-20       Impact factor: 5.590

6.  Mouse prion protein (PrP) segment 100 to 104 regulates conversion of PrP(C) to PrP(Sc) in prion-infected neuroblastoma cells.

Authors:  Hideyuki Hara; Yuko Okemoto-Nakamura; Fumiko Shinkai-Ouchi; Kentaro Hanada; Yoshio Yamakawa; Ken'ichi Hagiwara
Journal:  J Virol       Date:  2012-03-07       Impact factor: 5.103

Review 7.  Prions, beta-sheets and transmissible dementias: is there still something missing?

Authors:  P P Liberski
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

8.  Changing a single amino acid in the N-terminus of murine PrP alters TSE incubation time across three species barriers.

Authors:  R M Barron; V Thomson; E Jamieson; D W Melton; J Ironside; R Will; J C Manson
Journal:  EMBO J       Date:  2001-09-17       Impact factor: 11.598

9.  A Japanese family with a variant of Gerstmann-Sträussler-Scheinker disease.

Authors:  Y Tanaka; K Minematsu; H Moriyasu; T Yamaguchi; C Yutani; T Kitamoto; H Furukawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-05       Impact factor: 10.154

10.  A novel PRNP-P105S mutation associated with atypical prion disease and a rare PrPSc conformation.

Authors:  E Tunnell; R Wollman; S Mallik; C J Cortes; S J Dearmond; J A Mastrianni
Journal:  Neurology       Date:  2008-10-28       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.